Glupride-MP1 Tablet SR
Marketer
Vaxova Drugs Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glupride-MP1 Tablet SR
Metformin-Glipizide extended-release tablets are a dual-action medication designed to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Administer this medication with food to prevent gastrointestinal discomfort. If a dose is missed, take it promptly; however, if nearing the next scheduled dose, omit the missed one and resume the regular regimen. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or meal skipping may increase hypoglycemia risk. Regular blood glucose monitoring is essential. Common adverse reactions may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption, as it may heighten the likelihood of side effects.
Primary Ingredients of Glupride-MP1 Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glupride-MP1 Tablet SR
Managing type 2 diabetes
Major Benefits of Glupride-MP1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glupride-MP1 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Glupride-MP1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glupride-MP1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glupride-MP1 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Glupride-MP1 Tablet SR works:
Glupride-MP1 SR tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glupride-MP1 Tablet SR use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glupride-MP1 tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glupride-MP1 tablets likely pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with consequent harm to the nursing child.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glupride-MP1 Tablet SR; dosage modification may be necessary. Severe kidney disease contraindicates Glupride-MP1 Tablet SR use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glupride-MP1 Tablet SR; dosage modification may be necessary. Consult a physician for guidance. Glupride-MP1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glupride-MP1 Tablet SR :
Should you forget a Glupride-MP1 Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glupride-MP1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |

